Lock RB - Search Results

1

Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells.

Napier CE, Veas LA, Kan CY, Taylor LM, Yuan J, Wen VW, James A, O'Brien TA, Lock RB, MacKenzie KL. Napier CE, et al. Among authors: lock rb. Biochim Biophys Acta. 2010 Oct;1803(10):1142-53. doi: 10.1016/j.bbamcr.2010.06.010. Epub 2010 Jul 7. Biochim Biophys Acta. 2010. PMID: 20619302 Free article.

2

Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies.

Liem NL, Papa RA, Milross CG, Schmid MA, Tajbakhsh M, Choi S, Ramirez CD, Rice AM, Haber M, Norris MD, MacKenzie KL, Lock RB. Liem NL, et al. Among authors: lock rb. Blood. 2004 May 15;103(10):3905-14. doi: 10.1182/blood-2003-08-2911. Epub 2004 Feb 5. Blood. 2004. PMID: 14764536 Free article.

3

Inactivation of p16INK4a, with retention of pRB and p53/p21cip1 function, in human MRC5 fibroblasts that overcome a telomere-independent crisis during immortalization.

Taylor LM, James A, Schuller CE, Brce J, Lock RB, Mackenzie KL. Taylor LM, et al. Among authors: lock rb. J Biol Chem. 2004 Oct 15;279(42):43634-45. doi: 10.1074/jbc.M402388200. Epub 2004 Aug 10. J Biol Chem. 2004. PMID: 15308640 Free article.

4

Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor.

Bachmann PS, Gorman R, Mackenzie KL, Lutze-Mann L, Lock RB. Bachmann PS, et al. Among authors: lock rb. Blood. 2005 Mar 15;105(6):2519-26. doi: 10.1182/blood-2004-05-2023. Epub 2004 Nov 30. Blood. 2005. PMID: 15572593 Free article.

5

FLT-3: a new focus in the understanding of acute leukemia.

Markovic A, MacKenzie KL, Lock RB. Markovic A, et al. Among authors: lock rb. Int J Biochem Cell Biol. 2005 Jun;37(6):1168-72. doi: 10.1016/j.biocel.2004.12.005. Epub 2005 Jan 26. Int J Biochem Cell Biol. 2005. PMID: 15778081 Review.

6

Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.

Wen VW, Wu K, Baksh S, Hinshelwood RA, Lock RB, Clark SJ, Moore MA, Mackenzie KL. Wen VW, et al. Among authors: lock rb. Cancer Res. 2006 Nov 15;66(22):10691-700. doi: 10.1158/0008-5472.CAN-06-0979. Cancer Res. 2006. PMID: 17108106

7

p53 determines multidrug sensitivity of childhood neuroblastoma.

Xue C, Haber M, Flemming C, Marshall GM, Lock RB, MacKenzie KL, Gurova KV, Norris MD, Gudkov AV. Xue C, et al. Among authors: lock rb. Cancer Res. 2007 Nov 1;67(21):10351-60. doi: 10.1158/0008-5472.CAN-06-4345. Cancer Res. 2007. PMID: 17974978

8

A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenografts.

Ong V, Liem NL, Schmid MA, Verrills NM, Papa RA, Marshall GM, Mackenzie KL, Kavallaris M, Lock RB. Ong V, et al. Among authors: lock rb. J Pharmacol Exp Ther. 2008 Feb;324(2):434-42. doi: 10.1124/jpet.107.128926. Epub 2007 Nov 6. J Pharmacol Exp Ther. 2008. PMID: 17986648

9

siRNA targeting the IRF2 transcription factor inhibits leukaemic cell growth.

Choo A, Palladinetti P, Holmes T, Basu S, Shen S, Lock RB, O'Brien TA, Symonds G, Dolnikov A. Choo A, et al. Among authors: lock rb. Int J Oncol. 2008 Jul;33(1):175-83. Int J Oncol. 2008. PMID: 18575764

10

Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase.

Yuan J, Yang BM, Zhong ZH, Shats I, Milyavsky M, Rotter V, Lock RB, Reddel RR, MacKenzie KL. Yuan J, et al. Among authors: lock rb. Oncogene. 2009 Jul 23;28(29):2678-89. doi: 10.1038/onc.2009.136. Epub 2009 Jun 1. Oncogene. 2009. PMID: 19483728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page